723,285 Shares in DENTSPLY SIRONA Inc. $XRAY Acquired by Great Hill Capital LLC

Great Hill Capital LLC purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 4th quarter, HoldingsChannel reports. The fund purchased 723,285 shares of the medical instruments supplier’s stock, valued at approximately $8,267,000. DENTSPLY SIRONA makes up approximately 0.8% of Great Hill Capital LLC’s holdings, making the stock its 14th largest position.

A number of other large investors have also recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in DENTSPLY SIRONA during the first quarter worth $26,000. Huntington National Bank boosted its stake in shares of DENTSPLY SIRONA by 292.9% in the 3rd quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 2,077 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in shares of DENTSPLY SIRONA by 337.9% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 2,122 shares during the last quarter. Farther Finance Advisors LLC increased its position in shares of DENTSPLY SIRONA by 119.1% during the 4th quarter. Farther Finance Advisors LLC now owns 3,773 shares of the medical instruments supplier’s stock worth $43,000 after purchasing an additional 2,051 shares in the last quarter. Finally, True Wealth Design LLC increased its position in shares of DENTSPLY SIRONA by 49.7% during the 3rd quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock worth $45,000 after purchasing an additional 1,181 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have commented on XRAY shares. Bank of America upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and boosted their price target for the company from $13.00 to $17.00 in a research report on Thursday, February 19th. Wells Fargo & Company lifted their target price on shares of DENTSPLY SIRONA from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, February 27th. Citigroup began coverage on DENTSPLY SIRONA in a report on Wednesday. They issued a “sell” rating and a $10.00 target price on the stock. Zacks Research upgraded DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Monday, March 2nd. Finally, UBS Group dropped their price target on DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating for the company in a report on Tuesday, February 3rd. Three equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus price target of $14.08.

DENTSPLY SIRONA Stock Down 1.4%

Shares of NASDAQ:XRAY opened at $12.05 on Thursday. The company has a quick ratio of 1.03, a current ratio of 1.51 and a debt-to-equity ratio of 1.50. The firm has a market cap of $2.41 billion, a P/E ratio of -4.02, a P/E/G ratio of 1.44 and a beta of 0.99. DENTSPLY SIRONA Inc. has a 12 month low of $9.85 and a 12 month high of $17.18. The company’s 50-day moving average price is $12.38 and its two-hundred day moving average price is $12.07.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 18.85% and a negative net margin of 16.25%.The company had revenue of $961.00 million for the quarter, compared to analyst estimates of $926.40 million. During the same quarter in the previous year, the company posted $0.26 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was up 6.2% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Gregory T. Lucier purchased 27,555 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were acquired at an average price of $14.24 per share, with a total value of $392,383.20. Following the completion of the purchase, the director directly owned 27,555 shares of the company’s stock, valued at $392,383.20. The trade was a ? increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director James D. Forbes purchased 5,000 shares of the firm’s stock in a transaction that occurred on Monday, March 9th. The stock was purchased at an average price of $12.48 per share, for a total transaction of $62,400.00. Following the acquisition, the director owned 10,000 shares of the company’s stock, valued at $124,800. The trade was a 100.00% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 70,000 shares of company stock worth $956,437 over the last quarter. Corporate insiders own 0.50% of the company’s stock.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.